BRISTOL-MYERS SQUIBB COMPANY |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.58 USD | -1.81% |
|
-4.80% | -17.04% |
| 05:12pm | Bristol Myers: national schizophrenia campaign | CF |
| 02:34pm | Bristol-Myers Squibb Says US FDA Reassigns Action Date Subcutaneous Nivolumab | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Other Pharmaceuticals | -1.86% | -4.80% | -17.04% | -35.32% | -10.26% | 87.9B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- BMY Stock
- Charts Bristol-Myers Squibb Company
- Comparison Chart
